Search
for
Sort by
Research 331–360 of 1000+
- P23 A case of visceral leishmaniasis presenting as seropositive erosive rheumatoid arthritis in an immunocompromised patient
- Investigating the interplay of social defeat stress and personality in male and female zebrafish
- Investigating the interplay of social defeat stress and personality in male and female zebrafish
- Editorial: Targeted immunological therapies in dermatology
- Radiographic Findings of Shoulder Involvement in Ankylosing Spondylitis
- General Dermatology
- Identifying key components and therapeutic targets of the immune system in hidradenitis suppurativa with an emphasis on neutrophils
- Miscellaneous conditions
- SnapshotDx Quiz: January 2021
- 5. HIV, Fungal and Infectious Diseases
- Use of platelet‐rich plasma in treating a wound infection following tophi rupture: A case report
- Current systemic treatment strategies for hidradenitis suppurativa
- Mechanisms and Research Advances in Drug Delivery Systems for Psoriasis and Atopic Dermatitis
- Cells to Surgery Quiz: April 2020
- T helper 17 cell/regulatory T-cell imbalance in hidradenitis suppurativa/acne inversa: the link to hair follicle dissection, obesity, smoking and autoimmune comorbidities
- Primary Care of Adult Women
- Beyond the Surface: Understanding Demodex and Its Link to Blepharitis and Facial Dermatoses
- Investigating the interplay of social defeat stress and personality in male and female zebrafish
- Folliculitis decalvans
- Annual Convention in the Time of COVID
- Folliculotropic mycosis fungoides complicated by eosinophilia: a case report
- The human microbiome: A critical player in health and disease
- A Review on Biological and Nutritional Value of Kiwi Fruit
- An updated review on acne
- Seborrheic Dermatitis Revisited: Pathophysiology, Diagnosis, and Emerging Therapies—A Narrative Review
- Erosive Pustular Dermatosis: Delving into Etiopathogenesis and Management
- A 30-Year-Old Man with Recurrent Scaling and Itching of the Scalp
- 802 Molecular effect of brepocitinib in hidradenitis suppurativa (HS)
- 671 Impaired follicular Nrf2 signaling: Potential early therapeutic target in hidradenitis suppurativa
- Botulinum toxin type A for the management of hidradenitis suppurativa.